Saturday 17 October 2026 Export OKYO’s income statement to Excel — free account

OKYO Pharma Limited Sponsored ADR

OKYO Healthcare Biotechnology

Insiders bought in the last twelve months.

1.41 0.02 −1.40%

Follow OKYO

Alert me

Market cap: $75.1M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '24	Mar '25	Sep '25	Mar '26
ROE Full definition →	+7 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(20.85)	(19.25)	(13.07)	(9.53)
Capital Expenditures Full definition →		—	(0.01)	—	(0.01)
Other line items
Cash ROIC Full definition →		334.24%	482.53%	(1,319.14%)	(28.94%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		4.77	1.10	7.17	0.43
Capex/Depreciation Full definition →		0.00	(0.87)	0.00	(2.03)
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		—	0.00	—	0.00
Capex to Sales Full definition →		—	0.00	—	0.00

Show all line items

Columns are period end dates